Literature DB >> 9754642

Trends in the incidence of non-melanocytic skin cancer (NMSC) treated in Australia 1985-1995: are primary prevention programs starting to have an effect?

M Staples1, R Marks, G Giles.   

Abstract

Non-melanocytic skin cancer (NMSC) is the most common cancer in Australia, but data on its incidence are not routinely collected by cancer registries. National surveys were conducted in 1985, 1990 and 1995 to estimate NMSC incidence. Trends in incidence between 1985 and 1995 have been examined to determine the impact of primary prevention campaigns aimed at controlling skin cancer in Australia. National random household surveys of Australians aged over 13 years were used to estimate NMSC incidence in 1985, 1990 and 1995. Age- and sex-specific rates by survey year were modelled using Poisson regression. Basal cell carcinoma (BCC) rates in 1995 were 788 per 100,000, an increase of 19% since 1985. Squamous cell carcinoma (SCC) rates rose by 93% over the same period, from 166 to 321 per 100,000. The ratio of BCC:SCC changed from 4:1 in 1985 to 2.5:1 in 1995. BCC rates in latitudes <29 degrees S remained at about 3 times those in latitudes >37 degrees S over the decade. The ratio of SCC incidence between these latitudes changed from around 7:1 to 3:1 over the same period. Although NMSC incidence rates continue to rise, there have been reductions in BCC observed in younger age groups. Incidence rates of NMSC continue to rise in Australia, but there is evidence of a reduction in BCC incidence in younger cohorts. This is evidence that public health campaigns to reduce sun exposure may be having a beneficial effect on skin cancer rates.

Entities:  

Mesh:

Year:  1998        PMID: 9754642     DOI: 10.1002/(sici)1097-0215(19981005)78:2<144::aid-ijc3>3.0.co;2-z

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

1.  Sunlight and health. Use of sunscreens does not risk vitamin D deficiency.

Authors:  R Marks
Journal:  BMJ       Date:  1999-10-16

2.  Cohort studies (and skin cancer) never come alone.

Authors:  Joris A C Verkouteren; Robert J T van der Leest; Tamar Nijsten
Journal:  J Invest Dermatol       Date:  2015-03       Impact factor: 8.551

Review 3.  Towards skin cancer prevention and early detection: evolution of skin cancer awareness campaigns in Australia.

Authors:  Michelle R Iannacone; Adèle C Green
Journal:  Melanoma Manag       Date:  2014-09-05

4.  Staged-surgery with permanent pathology for the management of high-risk nonmelanoma skin cancer of the nose.

Authors:  Görkem Eskiizmir; Gülsüm Gençoğlan; Peyker Temiz; Zafer Hirçin; Aylin Ermertcan
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-07-08       Impact factor: 2.503

Review 5.  Basal cell carcinoma.

Authors:  Anthony Ormerod; Sanjay Rajpara; Fiona Craig
Journal:  BMJ Clin Evid       Date:  2010-04-06

Review 6.  Childhood exposure to ultraviolet radiation and harmful skin effects: epidemiological evidence.

Authors:  Adèle C Green; Sarah C Wallingford; Penelope McBride
Journal:  Prog Biophys Mol Biol       Date:  2011-09-03       Impact factor: 3.667

Review 7.  Health economic evaluation of non-melanoma skin cancer and actinic keratosis.

Authors:  Mitchell K Higashi; David L Veenstra; Paul C Langley
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

Review 8.  [Skin tumors in facial plastic surgery].

Authors:  W Heppt
Journal:  HNO       Date:  2009-04       Impact factor: 1.284

9.  The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.

Authors:  Roderick J Hay; Nicole E Johns; Hywel C Williams; Ian W Bolliger; Robert P Dellavalle; David J Margolis; Robin Marks; Luigi Naldi; Martin A Weinstock; Sarah K Wulf; Catherine Michaud; Christopher J L Murray; Mohsen Naghavi
Journal:  J Invest Dermatol       Date:  2013-10-28       Impact factor: 8.551

10.  Incidence of Multiple vs First Cutaneous Squamous Cell Carcinoma on a Nationwide Scale and Estimation of Future Incidences of Cutaneous Squamous Cell Carcinoma.

Authors:  Selin Tokez; Loes Hollestein; Marieke Louwman; Tamar Nijsten; Marlies Wakkee
Journal:  JAMA Dermatol       Date:  2020-12-01       Impact factor: 10.282

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.